INTRODUCTION
============

Physical inactivity can result in decreased fat-free mass (FFM), increased total fat mass (FM) and trunk fat, and contributes to the development of morbidities such as dyslipidemia (high levels of low-density lipoprotein cholesterol \[LDL-c\] and low high-density lipoprotein cholesterol \[HDL-c\]) and metabolic syndrome ([@b16-jer-12-6-559]). Additionally, lack of physical activity favors changes in blood coagulation and fibrinolysis, and increases the risk of cardiovascular diseases such as atherosclerosis, which is the leading cause of death worldwide ([@b26-jer-12-6-559]). On the other hand, physical activity or exercise training that improves cardiovascular fitness has been shown to improve lipid profile and blood fibrinolysis ([@b29-jer-12-6-559]).

Plasminogen activator inhibitor-1 (PAI-1) is a major inhibitor of fibrinolysis that increases the risk of ischemic cardiovascular events ([@b30-jer-12-6-559]) and is elevated in sedentary subjects compared to trained athletes ([@b19-jer-12-6-559]). Several studies have shown significant benefits in lipid profile, coagulation and fibrinolytic responses, primarily after moderate and maximal aerobic exercise protocols ([@b15-jer-12-6-559]; [@b23-jer-12-6-559]), but also in response to strength exercise ([@b22-jer-12-6-559]). [@b1-jer-12-6-559] compared low- versus high-volume resistance training with a control group and reported greater reductions in PAI-1 with higher volume resistance training after 5 sets of 9 exercises in healthy subjects. [@b22-jer-12-6-559] performed 6 sets of 10 repetitions on leg extension with 70% of one maximum repetition (1RM) and 120 sec of recovery intervals in healthy women with age between 18--28 years old and observed an increase in tissue plasminogen activator (tPA) but no difference in PAI-1 or markers of coagulation. Additionally, body fat percentage was negatively correlated to the tPA response to exercise (*r*=−0.44), and positively related to PAI-1 at baseline (*r*=0.47) and postexercise (*r*=0.47).

It is well-known that strength training has anticatabolic effects and can improve skeletal muscle carbohydrate metabolism ([@b18-jer-12-6-559]), while changes in fat utilization depends on a dose--response relationship to the volume of resistance exercise ([@b28-jer-12-6-559]). Thus, when a higher volume of exercise is performed there is a higher lipoprotein lipase activity and energy expenditures that improve lipid profiles PAI-1. Several studies have shown that an acute bout of intense exercise can induce a significant activation of fibrinolysis ([@b1-jer-12-6-559]; [@b4-jer-12-6-559]; [@b8-jer-12-6-559]; [@b17-jer-12-6-559]; [@b22-jer-12-6-559]), likely mediated by the release of tPA from the vascular endothelial cells. tPA concentrations in response to resistance exercise appear to be volume dependent and occur in both healthy subjects ([@b9-jer-12-6-559]) and patients with coronary artery disease ([@b8-jer-12-6-559]). We previously demonstrated that moderate intervals of recovery (90 sec) with a moderate load (70% 1RM) increase the anti-inflammatory cytokine interlukin-6 compared to short intervals of recovery (30 sec) ([@b27-jer-12-6-559]), however, it is not known how different recovery intervals influence lipid profile and PAI-1 response in healthy subjects after exhaustive strength exercise.

Thus, the purpose of this study was to investigate the influence of short (30 sec) and moderate (90 sec) recovery intervals on blood lipids and PAI-1 following exhaustive strength exercise in recreational weightlifters. Our hypothesis is that a high-intensity strength exercise session with moderate recovery intervals (90 sec) will improve the acute lipid profile and reduce PAI-1 compared to short recovery intervals (30 sec).

MATERIALS AND METHODS
=====================

Experimental approach to the problem
------------------------------------

To investigate the effect of exhaustive strength exercise with two different rest periods between sets (30 and 90 sec) on the lipid profile response and fibrinolysis, data was collected using a randomized and counterbalanced within-subjects design. Subjects performed the two exercise sessions separated by 72 hr. The test of 1RM was determined on nonconsecutive days, one week before the exercise protocols for all subjects. Height and total mass were measured with the subjects wearing light clothing on the same morning as the Dual-Energy X-ray Absorptiometry (DXA scan). Blood samples were collected pre exercise, immediately post exercise, and post-15 min and post-30 min into recovery ([Fig. 1](#f1-jer-12-6-559){ref-type="fig"}).

Subjects
--------

Seven male subjects with strength training experience (\>6 months) voluntarily participated in this study. All subjects performed weight training with a mean frequency of four sessions per week, for approximately 1 hr per session. Inclusion criteria for participation in the study were: age between 20 to 32 years; no contraindications involving the cardiovascular system, muscles, joints, or bones of the lower limbs, as regarding the practice of strength training. This study was conducted in accordance with the Helsinki Declaration. The project was approved by the Ethics Research Group of the São Paulo State University (Protocol: 2279 3414.7.0000.5402). Informed consent was obtained from all participants.

Anthropometric measurements and dietary intake assessment
---------------------------------------------------------

Body weight was measured using an electronic scale (Filizola PL 50, Filizola Ltda., Brazil) with a precision of 0.1 kg. Body composition was estimated using a DXA scanner (Lunar DPX-NT ver. 4.7, GE Healthcare, Buckinghamshire, England). The subjects were positioned in a supine position and remained immobile throughout the examination. FM and FFM were assessed and expressed in percentage values. All measurements were carried out at the University laboratory in a temperature-controlled room. Each morning, before the beginning of the measurements, the equipment was calibrated by the same researcher according to the manufacturer's instructions. Anthropometry consisted of body weight and height measurements. Height was measured on a fixed stadiometer with an accuracy of 0.1 cm and a length of 2.20 m.

Diet was not standardized; however participants were required to eat three hours prior to all testing sessions. Participants were instructed by a nutritionist how to complete the food records and were required to record all foods consumed on the day of each testing session. Nutrition data was analyzed for energy intake and macronutrient distribution using the NutWin software ver. 1.5 (Programa de Apoio à Nutrição, Universidade Federal de São Paulo, Brazil, 2002).

Test of 1RM
-----------

The 1RM test consisted of a five minutes of warm-up (jogging), followed by the performance of one set of 10 repetitions of each exercise at approximately 50% of the body mass. The load was increased gradually (10%--15%) during the test until the participants were no longer able to perform the entire movement, and 3 to 5 min of recovery were provided between attempts ([@b21-jer-12-6-559]). No rest was allowed between the concentric and eccentric phases of the movement, and the participants were encouraged verbally to exert a maximum effort. The test of 1RM was performed using the squat and bench press exercises. In addition, for better control of the 1RM test procedures, a wooden seat with adjustable heights was placed behind the participant in order to keep the bar displacement and knee angle (\~90°) constant on each half-squat repetition. Two fitness professionals supervised all testing sessions. One week prior to testing the participants performed four sets of 10--12 repetition in each exercise 3 times per week (Monday, Wednesday, and Friday) for familiarization with equipment.

Experimental protocol
---------------------

The exercise order for all sessions was squats followed by bench press. In both conditions subjects performed 4 sets of squat and bench press (totaling 8 sets) using 90% of the 1RM. In the short-interval condition 30 sec (30-sec condition) of rest was allowed between sets and exercises, whereas in the moderate-interval condition 90 sec (90-sec condition) of rest were allowed between sets and exercises. All the sequences of exercises were performed for four sets until movement failure for each exercise with normal speed (1-sec eccentric and 1-sec concentric actions with 1-sec pause between each repetition) ([@b31-jer-12-6-559]).

At 72 hr after the 1RM test subjects performed two randomized exercise sessions separated by 72-hr interval. Before the exercise sessions, five minutes of warm-up (jogging) was performed. During the exercise sessions subjects were verbally encouraged to perform all sets until exhaustion in each exercise. The total number of repetitions performed was recorded for each set of each exercise and for all sequences, and used to analyze workload and performance. All the sequences of exercises were performed 3-hr postprandial.

Blood samples and analysis
--------------------------

Blood samples were collected 3-hr postprandial. The blood samples (10 mL) were immediately allocated into two 5-mL vacutainer tubes (Becton Dickinson, BD, Juiz de Fora, Brazil) containing ethylenediaminetetraacetic acid for plasma separation and into one 5-mL dry vacutainer tube for serum separation. The tubes were centrifuged at 3.500 rpm for 15 min at 4°C, and plasma and serum samples were stored at −20°C until analysis. PAI-1 (0.16--10 ng/mL) was assessed using enzyme-linked immunosorbent assay commercial kits (R&D Systems, Minneapolis, MN, USA). Total cholesterol (standard 200 mg/dL), high-density lipoprotein (standard 20 mg/dL), and triacylglycerol (standard 200 mg/dL) were assessed using commercial kits (Labtest, São Paulo, Brazil). LDL was calculated according to ([@b10-jer-12-6-559]). To eliminate interassay variance, all samples were analyzed in identical runs.

Statistical analysis
--------------------

Data normality was verified using the Shapiro--Wilk test. The comparison of the maximum number of repetitions, food intake and macronutrient between conditions were analyzed using the Student t-test for independent samples. The differences in lipid profile (Chol, TAG, LDL, HDL-c) and PAI-1 were analyzed via a two-way analysis of variance (condition×time) with repeated measures. When a significant difference in condition or interaction was observed, a Tukey *post hoc* test was conducted. For all measured variables, the estimated sphericity was verified according to Mauchly's W test, and the Greenhouse--Geisser correction was used when necessary. Finally, Pearson correlation (*r*) analyzed the relationship between "mean differences" for PAI-1 concentration in both conditions (Immediately post exercise minus baseline) with "mean differences" for lipids profile across time (immediately postexercise minus baseline; post-15 exercise minus immediately postexercise; and post-30 exercise minus immediately post exercise) and body composition. Statistical significance was set at *P*\<0.05. The data were analyzed using the Biostat (version 5.0).

RESULTS
=======

[Table 1](#t1-jer-12-6-559){ref-type="table"} presents the mean values of age, height, weight, percentage of FM, percentage of fat free mass, and total energy intake and macronutrient distribution. There were no statistically significant differences in total food intake and macronutrient distribution between conditions. There were significant differences between condition for performance in bench press (number of repetitions: 30 sec=8.3±2.7×90 sec=14.6±4.0 repetition, *P*= 0.005) and a trend for differences in squat (number of repetitions: 30 sec=16.7±7.8×90 sec=30.4±14.9 repetition, *P*=0.052).

[Table 2](#t2-jer-12-6-559){ref-type="table"} presents the change in lipid profile across time between conditions. There was no main effect of time for LDL-c (*F*=1.826, *P*=0.201), but there was a trend for differences between conditions (*F*=9.645, *P*=0.053). For HDL-c there was no main effect of time (*F*=2.539, *P*=0.096) and a statistically significant main effect was found for condition (*F*=21.848, *P*=0.005); however, *post hoc* analysis found no significant differences between conditions at any time point nor when the data was pooled. There was no main effects of time for the Chol/HDL ratio (*F*=1.530, *P*= 0.257) nor differences between condition (*F*=0.249, *P*=0.644). There were no significant differences between time and condition for Chol and TAG. There were no interactions (condition×time) for any lipid profile variable.

There were no main effects of time for PAI-1 concentration (*F*=0.741, *P*=0.542) nor differences between condition (*F*= 2.264, *P*=0.183), however, a significant interaction was found (time×condition: *F*=3.309, *P*=0.044) ([Fig. 2](#f2-jer-12-6-559){ref-type="fig"}). PAI-1 decreased immediately postexercise in 90-sec condition (pre, 7.75±2.93; immediately, 5.31±4.64; post-15, 6.42±3.36; post-30, 6.6± 4.00 ng/mL; *P*=0.073) but no differences were found for the 30-sec condition (pre, 6.96 ±3.55; immediately, 7.35±3.04; post-15, 6.36±3.7; post-30, 6.46±3.45 ng/mL; *P*=0.303).

[Table 3](#t3-jer-12-6-559){ref-type="table"} presents the correlation values between PAI-1, lipid profile and body composition according to condition. For PAI-1 in the 90-sec condition, there was a significant positive stronger correlation with Chol changes immediately post-exercise and 15-min postexercise and LDL 15-min postexercise. There were significant positive correlations between 30-sec condition PAI-1 concentrations and TAG immediately postexercise. In both conditions there significant positive correlations between PAI-1 and FFM%. There was no significant correlations between PAI-1 and FM% in either condition analyzed.

DISCUSSION
==========

The main findings of the present study was that moderate rest intervals induced a reduction in PAI-1 levels postexercise compared to short rest intervals. Postexercise decreases in PAI-1 levels were strongly correlated to acute decreases in total cholesterol and LDL-c with moderate rest only and with fat free mass percentage in both conditions.

A recent systematic review concluded that strength training promotes an improvement in the lipid profile, especially regarding decreases in LDL-c concentrations ([@b29-jer-12-6-559]), and these positive strength exercise adaptations on the lipoprotein profile seem to occur regardless of obesity status ([@b25-jer-12-6-559]). In the present study HDL-c concentrations were elevated postexercise (in the 90-sec condition) (52.2%), however this difference did not reach statistical significance. [@b20-jer-12-6-559] investigated four intensities of acute bench press strength exercise (50%, 75%, 90%, and 110% 1RM) with 2 min of rest between sets on the lipoprotein profile and reported low (50% 1RM) and moderate (75% 1RM) intensities positively modified the lipoprotein profile whereas there were no significant changes following the higher intensity sessions (90% and 110% 1RM). In our study the greatest number of repetitions were performed with 90-sec condition of rest, and in [@b20-jer-12-6-559] the greatest number of repetitions were performed with 50% 1RM, which translated to the largest increases in HDL-c and decreases in TAG levels. Thus, the results these studies suggest that manipulating intensity and recovery interval to achieve higher overall volumes may be optimal for improving a patient's lipid profile. Reiterating the importance of the present findings, a classical study showed that an incremental increase of 1 mg/dL in high-density lipoprotein was associated with a significant decrease of coronary heart disease risk of more than 2%, and a reduction of more than 3% of cardiovascular disease mortality rates, regardless sex ([@b13-jer-12-6-559]).

Improvements in the lipid profile following an acute strength training session may be due to an increase in the reverse cholesterol transport pathway. To the best of our knowledge, only one study has investigated the proteins involved in reverse cholesterol transport after acute strength training. [@b12-jer-12-6-559] evaluated the response of lipid profile and lymphocyte cholesterol efflux regulatory protein (CERP) expression at three different intensities (40%, 60%, and 80% of 1RM) with 60 sec of rest period during circuit strength training. They found that 60% and 80% 1RM intensities improved lipid profile via a decrease in very low-density lipoprotein and atherogenic index. Moreover, all three intensities resulted in an increase of CERP expression in lymphocytes.

PAI-1 both inhibits fibrinolysis and has pleiotropic properties that are upregulated in pathological states, such as metabolic syndrome or chronic inflammation ([@b14-jer-12-6-559]). Fibrin and fibrin degradation products can be localized in the atherosclerotic plaque inducing the fibrinolytic process ([@b5-jer-12-6-559]), however, higher PAI-1 concentrations demonstrate atherogenic properties by stabilizing fibrin. As such, PAI-1 is associated with a higher incidence of myocardial infarction ([@b32-jer-12-6-559]), metabolic syndrome ([@b11-jer-12-6-559]), sedentary behavior ([@b19-jer-12-6-559]) and cancer ([@b2-jer-12-6-559]).

PAI-1 levels decreased 31.5% immediately postexercise in the 90-sec condition only. In agreement with these findings, [@b1-jer-12-6-559] compared three different intensities (40%, 60%, and 80% of 1RM) with preset repetitions (10, 7, and 5, respectively) on platelet aggregation in healthy male subjects during upper and lower body exercise and concluded that only 80% 1RM increased platelet aggregation and beta-thromboglobulin. The discrepancy between these results and those of [@b20-jer-12-6-559] whereby lower intensities had a more significant impact on PAI-1 levels were likely due to the study design. In [@b20-jer-12-6-559] all sets were taken to momentary muscular failure, whereas in [@b1-jer-12-6-559] the sets were stopped approximately 15, 10, and 3, respectively, repetitions prior to predicted momentary muscular failure ([@b21-jer-12-6-559]).

[@b6-jer-12-6-559] investigated the behavior of the coagulation system following near-maximal tests in competitive athletes (marathon runners, rowers, competitive weight lifters, and sedentary controls) on their respected modes of exercises (treadmill, rowing ergometer, loaded barbells, and cycle ergometer, respectively) and found similar increased tPA and decrease PAI-1 levels only after rowing and running. The low volume of the weight lifting tests may explain the lack of significant changes following the resistance training tests. In contrast, [@b8-jer-12-6-559] verified the coagulation and fibrinolytic responses after one set of 10 repetitions to volitional fatigue with 60 sec of recovery intervals during eight exercises in patients with coronary artery disease and observed increased tPA and decreased PAI-1 immediate postexercise. Furthermore, the reduction in PAI-1 levels persisted at 1-hr postexercise, showing that strength training seems to positively modulate the fibrinolytic system through increased tPA concentrations and decrease PAI-1 concentrations in both healthy subjects and patients with cardiovascular disease.

We found a positive relationship between lipid profile and PAI-1 levels, in that postexercise decreases in PAI-1 were strongly correlated with decreases in total cholesterol and LDL-c only in the 90-sec condition ([Table 3](#t3-jer-12-6-559){ref-type="table"}). In agreement with our results, [@b24-jer-12-6-559] correlated PAI-1 and lipid profile in 3,596 healthy men and women and observed positive but weak correlations with Chol (men: *r*=0.20 and women: *r*=0.13, *P*\<0.001) and TAG (men: *r*=0.48, women: *r*=0.32, *P*\<0.001), and a negative correlation with HDL-c (men: *r*=−0.25, women: *r*=−0.26). In addition, [@b11-jer-12-6-559] compared metabolic syndrome and healthy young adults and found positive associations between PAI-1, body mass index and percentage of FM. [@b7-jer-12-6-559] correlated PAI-1, leptin, lipid profile and body composition in nondiabetic women aged 18 to 45 years and observed a positive correlation between PAI-1 and FM (*r*=0.33, *P*\<0.001), leptin plasma (*r*=0.49, *P*\<0.001) and FFM (*r*=0.33, *P*\<0.01). We did not find any significant correlations between PAI-1 levels and percentage of FM, but greater decreases in PAI-1 were correlated with higher lean mass, suggesting that leaner body compositions may positively influence fibrinolysis.

The intervals of recovery used in this study were selected because they represent common rest intervals often employed by strength coaches and personal trainers as well as by competitive and recreational lifters in their practices. Despite the relevance and novelty of these results, it is necessary to mention some limitations; (a) Total volume was not matched between conditions; (b) The small sample size and the training status of the participants (recreational weightlifters) may be have decreased the response on the variables analyzed. If the subject pool was older or at a higher risk of ischemic events there may have been a greater likelihood for changes in PAI-1; (c) In our study only PAI-1 was measured. Measuring tPA in future studies will provide a better understanding of the effects of resistance training variables on coagulation, as some studies observed changes in tPA without statistically significant difference in PAI-1 concentration ([@b22-jer-12-6-559]) or relationships between variables ([@b3-jer-12-6-559]).

In summary, we conclude that short and moderate intervals of recovery improve acute lipid profile after heavy strength exercise but only 90 sec induced a higher reduction in PAI-1 concentration in recreational weightlifters. Furthermore, there was strong positive correlation between changes PAI-1, lipid profile and percentage of FFM in healthy subjects.

This study demonstrates to coaches, trainers, and clinicians that short (30 sec) and moderate (90 sec) intervals of recovery can be used when the objective of training is to improve lipid profile, however, moderate intervals of recovery seem to induce greater benefits on blood fibrinolysis in healthy subjects, likely due to the greater volume accomplished. Furthermore, resistance training in this fashion may be an effective non-pharmacological strategy in the attenuation of atherosclerosis, thereby reducing prescription medicine requirements during the aging process.
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###### 

General characteristics of the sample (n=7)

  Variable                    Mean±SD       
  --------------------------- ------------- ------------
  Age (yr)                    24.6±4.1      
                                            
  Height (cm)                 176.5±10.1    
                                            
  Weight (kg)                 76.1±8.3      
                                            
  Fat mass (%)                18.8±6.4      
                                            
  Fat free mass (%)           58.2±6.5      
  Dietary intake              30 sec        90 sec
   Total food intake (kcal)   824.0±640     935±532
   Carbohydrates (g)          125.7±127.6   134.7±99.3
   Protein (g)                43.7±29.7     40.9±34.4
   Lipids (g)                 16.3±9.2      26.3±11.4

SD, standard deviation.

###### 

Comparison on lipid profile between interval recovery in recreational weightlifters

  Variable           Recovery Intervals   *P*-value     
  ------------------ -------------------- ------------- -------
  Chol (mg/dL)                                          0.440
   Pre               134.0±45.1           125.4±43.0    
   Immediately       137.4±50.1           131.4 ±47.6   
   Post-15           138.2±51.2           135.4±44.3    
   Post-30           135.7±45.4           167.9 ±74.4   
                                                        
  LDL-c (mg/dL)                                         0.266
   Pre               82.0±19.5            75.9±30.8     
   Immediately       73.9±16.4            66.2±35.5     
   Post-15           96.7±12.9            79.3±32.0     
   Post-30           80.3±30.2            89.9±23.5     
                                                        
  HDL-c (mg/dL)                                         0.082
   Pre               53.5±9.2             55.8±11.1     
   Immediately       61.4±11.4            84.9±27.8     
   Post-15           57.8±8.5             61.8±9.7      
   Post-30           57.5±7.7             62.1±20.5     
                                                        
  TAG (mg/dL)                                           0.126
   Pre               117.3±25.4           103.6±13.1    
   Immediately       131.1±37.5           110.4±12.3    
   Post-15           122.1±31.5           102.9±13.3    
   Post-30           113.3±21.0           103.7±11.8    
                                                        
  Chol/HDL (mg/dL)                                      0.153
   Pre               2.5±1.1              2.5±1.2       
   Immediately       2.2±0.7              1.9±1.2       
   Post-15           2.5±1.1              2.3±1.0       
   Post-30           2.4±1.0              3.1±1.6       

Chol, total cholesterol; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; TAG, triacylglycerol.

###### 

Correlation between PAI-1, lipid profile and body composition according different recovery interval in recreational weightlifters

  Variable                 PAI-1                                               PAI-1
  ------------------------ --------------------------------------------------- ---------------------------------------------------
  Chol (mg/dL- 30 sec)                                                         
   Immediately             0.63                                                \-
   Post-15                 0.77                                                \-
   Post-30                 0.75                                                \-
                                                                               
  Chol (mg/dL- 90 sec)                                                         
   Immediately             \-                                                  0.91[\*](#tfn4-jer-12-6-559){ref-type="table-fn"}
   Post-15                 \-                                                  0.84[\*](#tfn4-jer-12-6-559){ref-type="table-fn"}
   Post-30                 \-                                                  0.14
                                                                               
  LDL-c (mg/dL- 30 sec)                                                        
   Immediately             0.55                                                \-
   Post-15                 0.33                                                \-
   Post-30                 0.68                                                \-
                                                                               
  LDL-c (mg/dlL- 90 sec)                                                       
   Immediately             \-                                                  0.72
   Post-15                 \-                                                  0.88[\*](#tfn4-jer-12-6-559){ref-type="table-fn"}
   Post-30                 \-                                                  0.75
                                                                               
  HDL-c (mg/dL- 30 sec)                                                        
   Immediately             0.28                                                \-
   Post-15                 −0.17                                               \--
   Post-30                 −0.30                                               \-
                                                                               
  HDL-c (mg/dL- 90 sec)                                                        
   Immediately             \-                                                  −0.006
   Post-15                 \--                                                 −0.21
   Post-30                 \-                                                  −0.26
                                                                               
  TAG (mg/dL- 30 sec)                                                          
   Immediately             0.87[\*](#tfn4-jer-12-6-559){ref-type="table-fn"}   \-
   Post-15                 0.76                                                \-
   Post-30                 0.78                                                \-
                                                                               
  TAG (mg/dL- 90 sec)                                                          
   Immediately             \-                                                  0.11
   Post-15                 \-                                                  0.51
   Post-30                 \-                                                  0.18
                                                                               
  FM% (baseline)                                                               
   Immediately             0.22                                                −0.07
   Post-15                 −0.26                                               −0.07
   Post-30                 −0.16                                               0.37
                                                                               
  FFM% (baseline)                                                              
   Immediately             0.74                                                0.77[\*](#tfn4-jer-12-6-559){ref-type="table-fn"}
   Post-15                 0.79[\*](#tfn4-jer-12-6-559){ref-type="table-fn"}   0.81[\*](#tfn4-jer-12-6-559){ref-type="table-fn"}
   Post-30                 0.81[\*](#tfn4-jer-12-6-559){ref-type="table-fn"}   0.68

Chol, total cholesterol; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; TAG, triacylglycerol; FM%, percentage of fat mass; FFM%, percentage of fat free mass.

*P*\<0.05.
